Cargando…

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies

Preclinical and early human clinical studies of broadly neutralizing antibodies (bNAbs) to prevent and treat HIV infection support the clinical utility and potential of bNAbs for prevention, postexposure prophylaxis, and treatment of acute and chronic infection. Observed and potential limitations of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Casey K., Ackerman, Margaret E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712301/ https://www.ncbi.nlm.nih.gov/pubmed/29234320 http://dx.doi.org/10.3389/fimmu.2017.01655

Ejemplares similares

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
por: Lewis, George K., et al.
Publicado: (2019)

Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections
por: Backes, Iara M., et al.
Publicado: (2022)

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Lee, Wen Shi, et al.
Publicado: (2021)

Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation
por: Lacek, Krzysztof, et al.
Publicado: (2014)

No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study)
por: Kling, Kendall D., et al.
Publicado: (2023)

Bispecific Antibodies: From Research to Clinical Application
por: Ma, Jiabing, et al.
Publicado: (2021)

Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
por: Lakhashe, Samir K., et al.
Publicado: (2022)

Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques
por: Lu, Pinyi, et al.
Publicado: (2021)

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s
por: Tolbert, William D., et al.
Publicado: (2022)

Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection
por: Jennewein, Madeleine F., et al.
Publicado: (2020)

Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review
por: Zaongo, Silvere D., et al.
Publicado: (2021)

Boosting of Markers of Fcγ Receptor Function in Anti-HIV Antibodies During Structured Treatment Interruption
por: Billings, Hugh, et al.
Publicado: (2019)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Anti-idiotype antibodies in cancer treatment
por: Gomez, Daniel E., et al.
Publicado: (2013)

A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential
por: Liu, Xiaolei, et al.
Publicado: (2022)

Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function
por: Crowley, Andrew R., et al.
Publicado: (2019)

The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications
por: Carter, Michael J., et al.
Publicado: (2017)

Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies
por: Carrillo, Jorge, et al.
Publicado: (2018)

Computationally-driven identification of antibody epitopes
por: Hua, Casey K, et al.
Publicado: (2017)

Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy
por: KC, Natasha, et al.
Publicado: (2022)

Immunogenicity of Anti-TNF-α Biotherapies: II. Clinical Relevance of Methods Used for Anti-Drug Antibody Detection
por: Bendtzen, Klaus
Publicado: (2015)

PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy
por: Shi, Ning, et al.
Publicado: (2022)

Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies
por: Kuang, Wenjing, et al.
Publicado: (2022)

Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
por: Bernard, Nicole F., et al.
Publicado: (2022)

HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression
por: Kammers, Kai, et al.
Publicado: (2021)

Targeting immune checkpoints in anti-neutrophil cytoplasmic antibodies associated vasculitis: the potential therapeutic targets in the future
por: Pan, Menglu, et al.
Publicado: (2023)

Clinical, imaging features and outcomes of patients with anti-GFAP antibodies: a retrospective study
por: Zhu, Bingqing, et al.
Publicado: (2023)

The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients
por: Chen, Xixia, et al.
Publicado: (2022)

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013)

Which Antibody Functions are Important for an HIV Vaccine?
por: Su, Bin, et al.
Publicado: (2014)

Neutralization-Enhancing RF Antibodies for HIV Vaccines
por: Suslov, Konstantin V.
Publicado: (2014)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody
por: Liu, Chenxi, et al.
Publicado: (2022)

SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity
por: Antosova, Zuzana, et al.
Publicado: (2022)

Editorial: HIV-Induced Damage of B Cells and Production of HIV Neutralizing Antibodies
por: Chiodi, Francesca, et al.
Publicado: (2018)

Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies
por: Doepker, Laura E, et al.
Publicado: (2021)

Potential contribution of anti-p200 autoantibodies to mucosal lesions in anti-p200 pemphigoid
por: Gao, Yangmin, et al.
Publicado: (2023)

Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity
por: Shen, Shanling, et al.
Publicado: (2020)

Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective
por: Gómez, Roberto E., et al.
Publicado: (2012)

Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies
por: Bharadwaj, Pranay, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vgf1r3ku2f22d36rv0hguukh29